{
  "input": {
    "mode": "execute_actions",
    "query": {
      "entity": "Generalised pustular psoriasis",
      "relation": "indication"
    },
    "items": [
      {
        "hypothesis_id": "H1",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "potential adverse effects",
            "expectation": "validate the potential risks associated with Acitretin and its effects on generalised pustular psoriasis",
            "assignee": "Skeptic"
          }
        ]
      },
      {
        "hypothesis_id": "H2",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "potential adverse effects",
            "expectation": "validate the potential risks associated with Apremilast and its effects on generalised pustular psoriasis",
            "assignee": "Skeptic"
          }
        ]
      },
      {
        "hypothesis_id": "H3",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "potential adverse effects",
            "expectation": "validate the potential risks associated with Etanercept and its effects on generalised pustular psoriasis",
            "assignee": "Skeptic"
          }
        ]
      }
    ],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_acitretin",
          "type": "Drug",
          "label": "Acitretin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_apremilast",
          "type": "Drug",
          "label": "Apremilast",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_etanercept",
          "type": "Drug",
          "label": "Etanercept",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_infliximab",
          "type": "Drug",
          "label": "Infliximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_secukinumab",
          "type": "Drug",
          "label": "Secukinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cyclosporine",
          "type": "Drug",
          "label": "Cyclosporine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_adalimumab",
          "type": "Drug",
          "label": "Adalimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_interleukin_17_inhibitors",
          "type": "Drug",
          "label": "Interleukin-17 inhibitors",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_topical_corticosteroids",
          "type": "Drug",
          "label": "Topical corticosteroids",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ustekinumab",
          "type": "Drug",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_thalidomide",
          "type": "Drug",
          "label": "Thalidomide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "d_generalised_pustular_psoriasis",
          "type": "Disease",
          "label": "Generalised Pustular Psoriasis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "t_inflam_regulation",
          "type": "Target",
          "label": "Inflammatory Regulation",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "p_psoriasis_pathway",
          "type": "Pathway",
          "label": "Psoriasis Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "p_acitretin_pathway",
          "type": "Pathway",
          "label": "Acitretin Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "p_apremilast_pathway",
          "type": "Pathway",
          "label": "Apremilast Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_psoriasis",
          "type": "Disease",
          "label": "Generalised pustular psoriasis",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_acitretin",
          "type": "Drug",
          "label": "Acitretin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_apremilast",
          "type": "Drug",
          "label": "Apremilast",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_etanercept",
          "type": "Drug",
          "label": "Etanercept",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_infliximab",
          "type": "Drug",
          "label": "Infliximab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_secukinumab",
          "type": "Drug",
          "label": "Secukinumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_cyclosporine",
          "type": "Drug",
          "label": "Cyclosporine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adalimumab",
          "type": "Drug",
          "label": "Adalimumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_il17_inhibitors",
          "type": "Drug",
          "label": "Interleukin-17 inhibitors",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_topical_corticosteroids",
          "type": "Drug",
          "label": "Topical corticosteroids",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ustekinumab",
          "type": "Drug",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_thalidomide",
          "type": "Drug",
          "label": "Thalidomide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot",
          "type": "Target",
          "label": "OffTargetR",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp",
          "type": "Pathway",
          "label": "RiskPathwayR",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv",
          "type": "Phenotype",
          "label": "AdverseEffects",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Acitretin",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Apremilast",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Etanercept",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Infliximab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Secukinumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Cyclosporine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Methotrexate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Adalimumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Interleukin-17 inhibitors",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Topical corticosteroids",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Thalidomide",
          "attrs": {
            "agent": "PI"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_acitretin",
          "target": "t_inflam_regulation",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "Acitretin已知对炎症调节的影响"
        },
        {
          "source": "drug_acitretin",
          "target": "p_acitretin_pathway",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Acitretin作用于特定通路"
        },
        {
          "source": "p_acitretin_pathway",
          "target": "d_generalised_pustular_psoriasis",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "通路调节与红斑性脓疱性银屑病的关联"
        },
        {
          "source": "drug_apremilast",
          "target": "t_inflam_regulation",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "Apremilast已知对炎症调节的影响"
        },
        {
          "source": "drug_apremilast",
          "target": "p_apremilast_pathway",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Apremilast作用于特定通路"
        },
        {
          "source": "p_apremilast_pathway",
          "target": "d_generalised_pustular_psoriasis",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "通路调节与红斑性脓疱性银屑病的关联"
        },
        {
          "source": "drug_etanercept",
          "target": "t_inflam_regulation",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "Etanercept已知对炎症调节的影响"
        },
        {
          "source": "drug_etanercept",
          "target": "p_psoriasis_pathway",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Etanercept作用于相关通路"
        },
        {
          "source": "p_psoriasis_pathway",
          "target": "d_generalised_pustular_psoriasis",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "通路调节与红斑性脓疱性银屑病的关联"
        },
        {
          "source": "n_acitretin",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在离靶作用可能引发风险"
        },
        {
          "source": "n_apremilast",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "机制尚不明确，可能引起不适"
        },
        {
          "source": "n_etanercept",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能涉及不良反应的靶点"
        },
        {
          "source": "n_infliximab",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "与免疫抑制相关的潜在风险"
        },
        {
          "source": "n_secukinumab",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "存在激活/抑制的争议"
        },
        {
          "source": "n_cyclosporine",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.65,
          "agent": "Skeptic",
          "rationale": "监测肾脏安全性有必要"
        },
        {
          "source": "n_methotrexate",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "耐受性问题和并发症风险"
        },
        {
          "source": "n_adalimumab",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.68,
          "agent": "Skeptic",
          "rationale": "对某些患者免疫相关风险"
        },
        {
          "source": "n_il17_inhibitors",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "可能带来新型反应"
        },
        {
          "source": "n_topical_corticosteroids",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.5,
          "agent": "Skeptic",
          "rationale": "长期用途的不良反应"
        },
        {
          "source": "n_ustekinumab",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "已知免疫抑制效果需警惕"
        },
        {
          "source": "n_thalidomide",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "与致畸性及其他副作用的关联"
        },
        {
          "source": "n_ot",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在风险通路的中介"
        },
        {
          "source": "n_rp",
          "target": "n_adv",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能引发多种不良效果"
        },
        {
          "source": "n_adv",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "潜在风险抵消药物收益"
        },
        {
          "source": "n_adv",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "潜在风险抵消药物收益"
        },
        {
          "source": "n_adv",
          "target": "H3",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "潜在风险抵消药物收益"
        },
        {
          "source": "n_adv",
          "target": "H4",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "潜在风险抵消药物收益"
        },
        {
          "source": "n_adv",
          "target": "H5",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "潜在风险抵消药物收益"
        },
        {
          "source": "n_adv",
          "target": "H6",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "潜在风险抵消药物收益"
        },
        {
          "source": "n_adv",
          "target": "H7",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "潜在风险抵消药物收益"
        },
        {
          "source": "n_adv",
          "target": "H8",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "潜在风险抵消药物收益"
        },
        {
          "source": "n_adv",
          "target": "H9",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "潜在风险抵消药物收益"
        },
        {
          "source": "n_adv",
          "target": "H10",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "潜在风险抵消药物收益"
        },
        {
          "source": "n_adv",
          "target": "H11",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "潜在风险抵消药物收益"
        },
        {
          "source": "n_adv",
          "target": "H12",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "潜在风险抵消药物收益"
        }
      ],
      "round_index": 2
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "hypothesis_id": "H1",
    "executed_actions": [
      {
        "action_ref": 0,
        "status": "done",
        "graph_updates": {
          "add_nodes": [
            {
              "id": "n_ot",
              "type": "Target",
              "label": "OffTargetR",
              "attrs": {
                "agent": "Skeptic"
              }
            },
            {
              "id": "n_rp",
              "type": "Pathway",
              "label": "RiskPathwayR",
              "attrs": {
                "agent": "Skeptic"
              }
            },
            {
              "id": "n_adv",
              "type": "Phenotype",
              "label": "AdverseEffects",
              "attrs": {
                "agent": "Skeptic"
              }
            }
          ],
          "add_edges": [
            {
              "source": "n_acitretin",
              "target": "n_ot",
              "relation": "acts_on",
              "weight": 0.7,
              "agent": "Skeptic",
              "rationale": "潜在离靶作用可能引发风险"
            },
            {
              "source": "n_ot",
              "target": "n_rp",
              "relation": "involved_in",
              "weight": 0.7,
              "agent": "Skeptic",
              "rationale": "潜在风险通路的中介"
            },
            {
              "source": "n_rp",
              "target": "n_adv",
              "relation": "causes",
              "weight": 0.8,
              "agent": "Skeptic",
              "rationale": "可能引发多种不良效果"
            },
            {
              "source": "n_adv",
              "target": "H1",
              "relation": "refutes",
              "weight": 0.85,
              "agent": "Skeptic",
              "rationale": "潜在风险抵消药物收益"
            }
          ],
          "merge": [],
          "set_weights": [],
          "conflict_hotspots": [
            {
              "topic": "potential adverse effects",
              "pro_nodes": [
                "n_acitretin"
              ],
              "con_nodes": [
                "n_adv"
              ],
              "note": "潜在风险可能抵消Acitretin的效益"
            }
          ]
        },
        "notes": "已完成对Acitretin的安全性压力测试"
      },
      {
        "action_ref": 1,
        "status": "done",
        "graph_updates": {
          "add_nodes": [],
          "add_edges": [
            {
              "source": "n_apremilast",
              "target": "n_ot",
              "relation": "acts_on",
              "weight": 0.6,
              "agent": "Skeptic",
              "rationale": "机制尚不明确，可能引起不适"
            },
            {
              "source": "n_ot",
              "target": "n_rp",
              "relation": "involved_in",
              "weight": 0.7,
              "agent": "Skeptic",
              "rationale": "潜在风险通路的中介"
            },
            {
              "source": "n_rp",
              "target": "n_adv",
              "relation": "causes",
              "weight": 0.8,
              "agent": "Skeptic",
              "rationale": "可能引发多种不良效果"
            },
            {
              "source": "n_adv",
              "target": "H2",
              "relation": "refutes",
              "weight": 0.85,
              "agent": "Skeptic",
              "rationale": "潜在风险抵消药物收益"
            }
          ],
          "merge": [],
          "set_weights": [],
          "conflict_hotspots": [
            {
              "topic": "potential adverse effects",
              "pro_nodes": [
                "n_apremilast"
              ],
              "con_nodes": [
                "n_adv"
              ],
              "note": "潜在风险可能抵消Apremilast的效益"
            }
          ]
        },
        "notes": "已完成对Apremilast的安全性压力测试"
      },
      {
        "action_ref": 2,
        "status": "done",
        "graph_updates": {
          "add_nodes": [],
          "add_edges": [
            {
              "source": "n_etanercept",
              "target": "n_ot",
              "relation": "acts_on",
              "weight": 0.7,
              "agent": "Skeptic",
              "rationale": "可能涉及不良反应的靶点"
            },
            {
              "source": "n_ot",
              "target": "n_rp",
              "relation": "involved_in",
              "weight": 0.7,
              "agent": "Skeptic",
              "rationale": "潜在风险通路的中介"
            },
            {
              "source": "n_rp",
              "target": "n_adv",
              "relation": "causes",
              "weight": 0.8,
              "agent": "Skeptic",
              "rationale": "可能引发多种不良效果"
            },
            {
              "source": "n_adv",
              "target": "H3",
              "relation": "refutes",
              "weight": 0.85,
              "agent": "Skeptic",
              "rationale": "潜在风险抵消药物收益"
            }
          ],
          "merge": [],
          "set_weights": [],
          "conflict_hotspots": [
            {
              "topic": "potential adverse effects",
              "pro_nodes": [
                "n_etanercept"
              ],
              "con_nodes": [
                "n_adv"
              ],
              "note": "潜在风险可能抵消Etanercept的效益"
            }
          ]
        },
        "notes": "已完成对Etanercept的安全性压力测试"
      }
    ],
    "unexecuted_actions": [],
    "residual_conflicts": [
      "潜在风险的影响需进一步探讨，可能影响长期获益"
    ]
  }
}